SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-07-014906
Filing Date
2007-03-02
Accepted
2007-03-02 13:40:49
Documents
2
Period of Report
2007-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 16497
2 POA DOCUMENT poa.txt EX-24.3_176121 2861
  Complete submission text file 0001209191-07-014906.txt   21145
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6455 NANCY RIDGE DRIVE SAN DIEGO X1 92121
Business Address 8586466649
SEIKKULA LUKE (Reporting) CIK: 0001391435 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 07666810